News articles

News article list

• NICE approves routine use of drug combination for advanced breast cancer

  A life-extending drug combination for some people with advanced breast cancer will now be available for routine use in the NHS.

• NICE recommends adjuvant treatment for melanoma

  Around 1,500 people aged 12 years and over with melanoma are set to benefit from pembrolizumab, a drug that reduces the chance of it returning.

• New guidance recommends transplant with good bacteria taken from poo

  Up to 500 people each year could be treated using faecal microbiota transplant for multiple recurrences of Clostridium difficile infections.

• KardiaMobile recommended for people having antipsychotic medication

  NICE publishes first draft guidance from its Early Value Assessment pilot project recommending smartphone-linked ECG device

• NICE recommends 2 new breast cancer drugs

  NICE recommends Piqray and Trodelvy, maintaining 100% approvals of breast cancer drugs since 2018.

• Change in treatment for people with early breast cancer to benefit around 4,000

  Around 4,000 people are set to benefit from a change in treatment for early breast cancer following provisional approval by NICE of abemaciclib in combination with hormone therapy.